期刊文献+

孟鲁司特钠联合酮替芬治疗咳嗽变异性哮喘的临床效果 被引量:3

Clinical effect of montelukast sodium combined with ketotifen in the treatment of cough variant asthma
下载PDF
导出
摘要 目的探讨孟鲁司特钠联合酮替芬治疗咳嗽变异性哮喘的临床效果。方法在本院2015年12月至2017年12月收治的咳嗽变异性哮喘患者中选取98例作为研究对象,并按给药方案不同分为对照组(n=49,单纯采用酮替芬治疗)和研究组(n=49,应用孟鲁司特钠联合酮替芬治疗)。比较两组患者治疗效果、复发率、肺功能指标水平及咳嗽评分。结果研究组患者的治疗总有效率为95.92%,显著高于对照组的81.63%,差异具有统计学意义(P<0.05)。研究组患者复发率是2.13%,显著低于对照组的16.67%,差异具有统计学意义(P<0.05)。治疗后,两组患者的肺功能指标FVC、FEV1、MVV水平均升高,且研究组显著高于对照组,差异具有统计学意义(P<0.05);两组患者的日间、夜间咳嗽评分均降低,且研究组低于对照组,差异具有统计学意义(P<0.05)。结论孟鲁司特钠联合酮替芬治疗咳嗽变异性哮喘的临床效果确切,值得临床推广应用。 Objective To explore the clinical effect of montelukast sodium combined with ketotifen in the treatment ofcough variant asthma. Methods A total of 98 patients with cough variant asthma admitted in our hospital from December2015 to December 2017 were selected as study objects. According to the different administration schedules, the patientswere divided into control group (n=49, treated with ketotifen alone) and study group (n=49, treated with montelukastsodium combined with ketotifen). The treatment effects, recurrence rate, levels of pulmonary function indexes and coughscores were compared between the two groups. Results The total effective rate of treatment in the study group was95.92%, which was significantly higher than 81.63% of the control group, the difference was statistically significant (P〈0.05); The recurrence rate in the study group was 2.13%, which was significantly lower than 16.67% of the controlgroup, the difference was statistically significant (P〈0.05). After treatment, the levels of lung function indicators such asFVC, FEV1 and MVV in the both groups increased, and those of the study group were sgnificantly higher than the controlgroup, the differences were statistically significant (P〈0.05); the daytime and nighttime cough scores of the two groupsdecreased, and those in the study group were lower than the control group, the differences were statistically significant(P〈0.05). Conclusion Montelukast sodium combined with ketotifen in the treatment of cough variant asthma hasaaccurate clinical effect. It is worthy of popularization and application in clinic.
作者 杨晓钟 马雯霞 YANG Xiao-zhong;MA Wen-xia(the Second Affiliated Hospital of Xi'an Medical University,Xi'an 710003,China)
出处 《临床医学研究与实践》 2018年第33期24-26,共3页 Clinical Research and Practice
关键词 孟鲁司特钠 酮替芬 咳嗽变异性哮喘 肺功能指标 montelukast sodium ketotifen cough variant asthma pulmonary function indexes
  • 相关文献

参考文献14

二级参考文献141

  • 1张颖,王伟.咳嗽变异型哮喘的研究进展[J].国外医学(呼吸系统分册),2004,24(3):160-161. 被引量:50
  • 2钟南山,赖克方.咳嗽的诊断与治疗指南(草案)[J].诊断学理论与实践,2006,5(2):187-192. 被引量:35
  • 3吴君华,柳晨,裴元英.布地奈德剂型的研究进展及其临床应用[J].中国临床药学杂志,2007,16(1):59-62. 被引量:34
  • 4洪建国.咳嗽变异性哮喘与儿童慢性咳嗽[J].临床儿科杂志,2007,25(6):431-434. 被引量:71
  • 5阎锡新,杨红申,郭丽萍.支气管哮喘[M].北京:军事医学科学出版社,2007:231-244.
  • 6Ali Bin Sarwar, Zubairi Nawal, Salahuddin Ali, et al. A random- ized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation [ J ]. BMC pulmonary medicine, 2013, 13:20.
  • 7Krishna M, Sundar Sarah E, Daly Alika M,et al. A longitudinal study of CPAP therapy for patients with chronic cough and obstruc- tive sleep apnoea [ J ]. Cough ( London, England ), 2013,9 ( 1 ) : 19.
  • 8Matsumoto H, Tabuena RP, Niimi A, et al. Cough triggers and their pathophysiology in patiets with prolonged or chronic cough [J]. AllergolInt,2013,61(1):123-132.
  • 9Kawada T. Prevalence of asthma and atopic dermatitis in chil- dren with special emphasis on birth order[J]. Pediatr Allergy Immunol,2012,23(2) :795.
  • 10Fisher T, Turcotte S E,Fisher J T, et al. Bronchodilating And Bronchoprotective Effects Of Deep Inspirations In Asthma, Cough Variant Asthma And MetKacholine -Induced Cough But Normal Airway Sensitivity[J]. Am J Respir Crit Care Med,2015,191:A4115.

共引文献679

同被引文献33

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部